Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10191)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2021 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang M, Zhang CY. G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment. World J Gastroenterol 2021; 27(8): 677-691 [PMID: 33716447 DOI: 10.3748/wjg.v27.i8.677] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i8/677.htm |
| Number | Citing Articles |
| 1 |
Veronika A. Prikhodko, Natalia N. Bezborodkina, Sergey V. Okovityi. Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. Biomedicines 2022; 10(2): 274 doi: 10.3390/biomedicines10020274
|
| 2 |
Darya A. Pon’kina, Sergey O. Kuranov, Mariya K. Marenina, Yulia V. Meshkova, Nataliya A. Zhukova, Mikhail V. Khvostov, Olga A. Luzina, Tatiana G. Tolstikova, Nariman F. Salakhutdinov. Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies. Pharmaceutics 2023; 15(6): 1670 doi: 10.3390/pharmaceutics15061670
|
| 3 |
Chunye Zhang, Yi Wang, Takefumi Kimura, Ahmad H. Al-Mrabeh. Editorial: The role of GPCRs in obesity. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1404969
|
| 4 |
Lena Heinrich, Richell Booijink, Amit Khurana, Ralf Weiskirchen, Ruchi Bansal. Lipoxygenases in chronic liver diseases: current insights and future perspectives. Trends in Pharmacological Sciences 2022; 43(3): 188 doi: 10.1016/j.tips.2021.12.001
|
| 5 |
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang. Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Exploration of Digestive Diseases 2023; : 246 doi: 10.37349/edd.2023.00029
|
| 6 |
Chunye Zhang, Ming Yang. Current Options and Future Directions for NAFLD and NASH Treatment. International Journal of Molecular Sciences 2021; 22(14): 7571 doi: 10.3390/ijms22147571
|
| 7 |
Chunye Zhang, Ming Yang. Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.789859
|
| 8 |
Isabel Cornejo-Pareja, Mohamed Reda Amiar, Luís Ocaña-Wilhelmi, Rocío Soler-Humanes, Isabel Arranz-Salas, Lourdes Garrido-Sánchez, Carolina Gutiérrez-Repiso, Francisco Jose Tinahones. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism. Journal of Gastroenterology 2024; 59(4): 329 doi: 10.1007/s00535-023-02075-7
|
| 9 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World Journal of Gastrointestinal Oncology 2022; 14(8): 1456-1468 doi: 10.4251/wjgo.v14.i8.1456
|
| 10 |
Junli Feng, Shitong Wang, Feifei Chen, Jian Zhang, Qingcheng Wang, Lili Jiang, Zejun Wang, Qing Shen. Effects of triglyceride and ethyl ester forms of EPA on hepatic lipid metabolism in mice with non-alcoholic fatty liver disease. Journal of Functional Foods 2024; 116: 106179 doi: 10.1016/j.jff.2024.106179
|
| 11 |
Youngmin A. Lee, Scott L. Friedman. Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies. Journal of Internal Medicine 2022; 291(1): 11 doi: 10.1111/joim.13380
|
| 12 |
Chunye Zhang, Shuai Liu, Ming Yang. Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.808526
|
| 13 |
Weiwei Li, Mingjuan Deng, Jiahui Gong, Yichao Hou, Liang Zhao. Bidirectional Regulation of Sodium Acetate on Macrophage Activity and Its Role in Lipid Metabolism of Hepatocytes. International Journal of Molecular Sciences 2023; 24(6): 5536 doi: 10.3390/ijms24065536
|
| 14 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Treatment of liver fibrosis: Past, current, and future. World Journal of Hepatology 2023; 15(6): 755-774 doi: 10.4254/wjh.v15.i6.755
Abstract(428) |
Core Tip(350) |
Full Article(HTML)(2967)
|
Full Article with Cover (PDF)-4268K(53)
|
Full Article (Word)-1195K(32)
|
Audio-303K(1)
|
Peer-Review Report-179K(28)
|
Answering Reviewers-123K(22)
|
Full Article (PDF)-1940K(332)
|
Full Article (XML)-339K(26)
|
Times Cited (7)
|
Total Visits (5465)
|
Open
|
| 15 |
Noorshafadzilah Talib, Nurul Elyani Mohamad, Swee Keong Yeap, Chai Ling Ho, Mas Jaffri Masarudin, Suraini Abd-Aziz, Mira Nadiah Mohd Izham, Muganti Rajah Kumar, Yazmin Hussin, Noorjahan Banu Alitheen. Anti-Diabetic Effect of Lactobacillus Paracasei Isolated from Malaysian Water Kefir Grains. Probiotics and Antimicrobial Proteins 2023; doi: 10.1007/s12602-023-10159-2
|
| 16 |
Ting Dong, Guangan Hu, Zhongqi Fan, Huirui Wang, Yinghui Gao, Sisi Wang, Hao Xu, Michael B. Yaffe, Matthew G. Vander Heiden, Guoyue Lv, Jianzhu Chen. Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-45167-5
|
| 17 |
Mengyao Wu, Tak-Ho Lo, Liping Li, Jia Sun, Chujun Deng, Ka-Ying Chan, Xiang Li, Steve Ting-Yuan Yeh, Jimmy Tsz Hang Lee, Pauline Po Yee Lui, Aimin Xu, Chi-Ming Wong. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1). eLife 2023; 12 doi: 10.7554/eLife.85131
|
| 18 |
Xueping Li, Weijun Cui, Yanfei Cui, Xinling Song, Le Jia, Jianjun Zhang. Stropharia rugoso-annulata acetylated polysaccharides alleviate NAFLD via Nrf2/JNK1/AMPK signaling pathways. International Journal of Biological Macromolecules 2022; 215: 560 doi: 10.1016/j.ijbiomac.2022.06.156
|
| 19 |
Renzhong Lu, Yan Li, Anna Xu, Bridgette King, Ke-He Ruan. Reprogramming Megakaryocytes for Controlled Release of Platelet-like Particles Carrying a Single-Chain Thromboxane A2 Receptor-G-Protein Complex with Therapeutic Potential. Cells 2023; 12(24): 2775 doi: 10.3390/cells12242775
|
| 20 |
Chengyuan Liang, Juan Li, Bin Tian, Lei Tian, Yuzhi Liu, Jingyi Li, Liang Xin, Jun Wang, Chao Fu, Zhenfeng Shi, Juan Xia, Yiting Liang, Kun Wang. Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. Biomedicine & Pharmacotherapy 2021; 144: 112298 doi: 10.1016/j.biopha.2021.112298
|
| 21 |
Antwi-Boasiako Oteng, Srinivas Pittala, Andrea Kliewer, Yishu Qiu, Jürgen Wess. Hepatic GRK2 is dispensable for glucose homeostasis and other key metabolic parameters in mice. Molecular Metabolism 2024; 79: 101866 doi: 10.1016/j.molmet.2023.101866
|
| 22 |
Li-Chiung Lin, Tezz Quon, Susanna Engberg, Amanda E. Mackenzie, Andrew B. Tobin, Graeme Milligan. G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes. ACS Pharmacology & Translational Science 2021; 4(6): 1835 doi: 10.1021/acsptsci.1c00224
|
| 23 |
Chunye Zhang, Ming Yang. Molecular targets regulating endoplasmic reticulum-mitochondria crosstalk for NAFLD treatment. Exploration of Medicine 2021; doi: 10.37349/emed.2021.00066
|
| 24 |
Darya Pon`kina, Sergey Kuranov, Mikhail Khvostov, Nataliya Zhukova, Yulia Meshkova, Mariya Marenina, Olga Luzina, Tatyana Tolstikova, Nariman Salakhutdinov. Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine. Molecules 2023; 28(1): 396 doi: 10.3390/molecules28010396
|